Results 21 to 30 of about 60,875 (277)
Application of digital micromirror devices (DMD) in biomedical instruments
Journal of Innovative Optical Health Sciences, 2020 There is an ongoing technological revolution in the field of biomedical instruments. Consequently, high performance healthcare devices have led to remarkable economic developments in the medical hardware industry.
Ziyun Zhuang, Ho Pui Ho
doaj +1 more source
Jurnal Agripet, 2021 ABSTRAK. Penelitian ini bertujuan untuk mengkaji nilai kecernaan bahan kering (KcBK), kecernaan bahan organik (KcBO), kecernaan lemak kasar (KcLK) dan total digestible nutrient (TDN) dari hijauan pakan kambing.
Puspadina Dwi Rahmawati +3 more
doaj +1 more source
Endodontic treatment of maxillary second molar with two roots – a case report [PDF]
Biomedicinska istraživanja, 2020 Introduction. The success of endodontic treatment depends on the adequate biomechanical preparation and obturation of the entire root canal system. The untreated or poorly debrided/obturated root canals are among the most frequent causes of endodontic ...
Dajana Nogo-Živanović, Dragan Ivanović, Tanja Ivanović, Ivana Simić
doaj +1 more source
Neuromuscular Disorders, 2017 Duchenne Muscular Dystrophy (DMD) is the most frequent muscular dystrophy in childhood, with a worldwide incidence of one in 5000 live male births. It is due to mutations in the dystrophin gene leading to absence of full-length dystrophin protein. Central nervous system involvement is well-known in Duchenne Muscular Dystrophy.
Cardas, R +10 more
openaire +4 more sources
Duchenne muscular dystrophy : mutation profiling in view of the emerging gene-based therapies [PDF]
, 2010 Includes bibliographical references (leaves 97-115).Duchenne Muscular Dystrophy (DMD) is a lethal, X-linked, recessive muscle-wasting disorder affecting 1 in 3 500 live male births worldwide, for which only palliative care is available to date.
Esterhuizen, Alina
core +1 more source
Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: Implication for clinical trials [PDF]
, 2010 Duchenne muscular dystrophy (DMD) is characterised by the absence of dystrophin in muscle biopsies, although residual dystrophin can be present, either as dystrophin-positive (revertant) fibres or traces.
Main, M +25 more
core +1 more source
, 2015 Wide-field fluorescent images of Dmd-Citrine expression in Gt(dmd-citrine)ct90a embryo in the trunk skeletal muscles at ...
Scott E. Fraser (178546) +3 more
core +2 more sources
Journal of Neuromuscular Diseases, 2020 The DMD gene is the largest in the human genome, with a total intron content exceeding 2.2Mb. In the decades since DMD was discovered there have been numerous reported cases of pseudoexons (PEs) arising in the mature DMD transcripts of some individuals, either as the result of mutations or as low-frequency errors of the spliceosome.
openaire +3 more sources
Patients Monitoring During Treatment With Injectable DMDs (INF and GA) (ORP-11) [PDF]
Neurology Letters, 2023 IFN-β : All interferons are approved for the treatment of RRMS, moreover Betaferon and Avonex are also approved for the treatment of clinical isolated syndrome (CIS) and Betaferon for the treatment of active secondary progressive MS (SPMS) as well (EMA ...
Zahra Nikoo
doaj
Proteomic profiling of Duchenne muscular dystrophy : protein patterns and candidate markers of disease [PDF]
, 2011 Duchenne muscular dystrophy (DMD) caused by mutations in the dystrophin gene is a severe chronic muscle-wasting disease leading to early loss of ambulation in patients and to death by the third decade.
Escher, Claudia Andrea
core +1 more source